|
|
|
|
|
|
by eighthnate
3122 days ago
|
|
|
Likely not. It'll most likely be India as they are the largest generics manufacturing nation by far. India is to generic drugs what we are to non-generics. Israel is another major generics manufacturer so it could be them. China's pharmaceutical market haven't developed as quickly because of their internal chinese medicine market. |
|
|
Even American generic manufacturers get a large percentage of their APIs from India. Surprise surprise, weak patent laws mean you get pretty good at making complex things.
The bulk mass-produced excipients/binders/“fillers” often come from China, since that’s what they’re good at.
Pressing tablets and packaging them is fairly commoditized work. The extra cost of doing it in the USA won’t make a perceptible difference to the end-user.
QC is easier when you’re working with verified pure ingredients.
I’m much more worried about food made with imported ingredients than drugs made with imported ingredients.
When a 500k tablet per hour rotary press can be tended to by a person or two and do its thing, labour costs aren’t very relevant.